/HYFT
HYFT Stock - MindWalk Holdings Corp.
Healthcare|BiotechnologyNASDAQ
$1.67+1.83%
+$0.03 (+1.83%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.70
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.84
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HYFT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.65 – $1.69
TARGET (TP)$1.92
STOP LOSS$1.54
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.70
52W High$3.25
52W Low$0.27
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $24.31M | $24.81M | $21.17M | $19.80M | $17.91M |
| Gross Profit | $11.50M | $9.19M | $7.32M | $9.17M | $11.40M |
| Gross Margin | 47.3% | 37.1% | 34.6% | 46.3% | 63.7% |
| Operating Income | $-12,269,861 | $-14,262,227 | $-29,253,209 | $-17,127,708 | $-5,284,208 |
| Net Income | $-29,974,707 | $-26,428,587 | $-27,213,241 | $-17,087,824 | $-7,340,000 |
| Net Margin | -123.3% | -106.5% | -128.5% | -86.3% | -41.0% |
| EPS | $-0.90 | $-1.02 | $-1.07 | $-0.85 | $-0.45 |
Company Overview
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HYFTBeat Rate
19%
Last 16 quarters
Avg Surprise
-77.6%
EPS vs Estimate
Beats / Misses
3/11
2 met exactly
Latest EPS
$-0.05
Q4 2025
EPS Surprise History
Q1 24
-7.5%
$-0.08vs$-0.07
Q3 24
-420.0%
$-0.52vs$-0.10
Q3 24
-22.2%
$-0.11vs$-0.09
Q4 24
0.0%
$-0.09vs$-0.09
Q1 25
0.0%
$-0.06vs$-0.06
Q3 25
-100.0%
$-0.04vs$-0.02
Q3 25
-75.0%
$-0.07vs$-0.04
Q4 25
-400.0%
$-0.05vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 27, 2026 | $-0.04 | — | — | — |
Q4 2025 | Dec 15, 2025 | $-0.01 | $-0.05 | -400.0% | ✗ MISS |
Q3 2025 | Sep 15, 2025 | $-0.04 | $-0.07 | -75.0% | ✗ MISS |
Q3 2025 | Jul 29, 2025 | $-0.02 | $-0.04 | -100.0% | ✗ MISS |
Q1 2025 | Mar 28, 2025 | $-0.06 | $-0.06 | 0.0% | = MET |
Q4 2024 | Dec 10, 2024 | $-0.09 | $-0.09 | 0.0% | = MET |
Q3 2024 | Sep 16, 2024 | $-0.09 | $-0.11 | -22.2% | ✗ MISS |
Q3 2024 | Jul 29, 2024 | $-0.10 | $-0.52 | -420.0% | ✗ MISS |
Q1 2024 | Mar 14, 2024 | $-0.07 | $-0.08 | -7.5% | ✗ MISS |
Q4 2023 | Dec 14, 2023 | $-0.09 | $-0.07 | +22.2% | ✓ BEAT |
Q3 2023 | Sep 14, 2023 | $-0.20 | $-0.14 | +30.0% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $-0.13 | $-0.10 | +21.0% | ✓ BEAT |
Q3 2023 | Jul 10, 2023 | $-0.12 | $-0.15 | -25.0% | ✗ MISS |
Q4 2022 | Dec 15, 2022 | $-0.14 | $-0.23 | -64.3% | ✗ MISS |
Q3 2022 | Sep 14, 2022 | $-0.17 | $-0.38 | -123.5% | ✗ MISS |
Q2 2022 | Apr 30, 2022 | — | $-0.17 | — | — |
Q1 2022 | Mar 16, 2022 | $-0.16 | $-0.20 | -25.0% | ✗ MISS |
Q4 2021 | Dec 13, 2021 | $-0.17 | $-0.26 | -52.9% | ✗ MISS |
Q3 2021 | Sep 9, 2021 | — | $-0.13 | — | — |
Q3 2021 | Jul 28, 2021 | — | $-0.24 | — | — |
Latest News
CORRECTION: MindWalk Holdings Q2 EPS $(0.05) Misses $(0.01) Estimate, Sales $2.973M Miss $4.000M Estimate
📉 NegativeBenzinga•Dec 15, 2025, 02:43 PM
MindWalk Advances AI-Designed GLP1 Program And Launches Segregated AI Asset Structure
📈 PositiveBenzinga•Dec 15, 2025, 01:39 PM
MindWalk Holdings Entered Sales Agreement With JonesTrading Institutional Services To Offer Up To $30M Common Shares
➖ NeutralBenzinga•Nov 7, 2025, 10:20 PM
MindWalk Holdings Appoints Scott Areglado As CFO
➖ NeutralBenzinga•Oct 21, 2025, 12:29 PM
MindWalk Holdings shares are trading higher after the company announced a 2.3 million share buyback program.
📈 PositiveBenzinga•Oct 9, 2025, 04:51 PM
CORRECTION: MindWalk Holdings Ticker Is HYFT Not HYFGF
➖ NeutralBenzinga•Oct 9, 2025, 04:51 PM
MindWalk Holdings shares are trading higher after the company announced a 2.3 million share buyback program.
📈 PositiveBenzinga•Oct 9, 2025, 01:11 PM
MindWalk Announces Share Repurchase Program, Plans to Buy Back 2.3M Shares Over the Next Year
📈 PositiveBenzinga•Oct 9, 2025, 11:09 AM•Also:
MindWalk shares are trading higher after the company announced an advancement of its AI-designed GLP-1 therapeutics program.
📈 PositiveBenzinga•Sep 22, 2025, 07:22 PM
Findings From MindWalk Lensai Platform, An AI-Designed GLP-1 Therapeutics Program, Support A Dual-pathway Regimen In Which MindWalk's Companion Therapeutic Is Co-administered With Its GLP-1 Receptor Agonists To Engage Both Mechanisms In Concert
📈 PositiveBenzinga•Sep 22, 2025, 11:11 AM
MindWalk Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results.
📉 NegativeBenzinga•Sep 15, 2025, 03:59 PM
MindWalk Holdings Q1 EPS $(0.07) Misses $(0.04) Estimate, Sales $2.301M Miss $4.130M Estimate
📉 NegativeBenzinga•Sep 15, 2025, 12:55 PM
Frequently Asked Questions about HYFT
What is HYFT's current stock price?
MindWalk Holdings Corp. (HYFT) is currently trading at $1.67 per share. The stock has moved +1.83% today.
What is the analyst price target for HYFT?
No analyst price targets are currently available for this stock.
What sector is MindWalk Holdings Corp. in?
MindWalk Holdings Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is HYFT's market cap?
MindWalk Holdings Corp. has a market capitalization of $0.08 billion, making it a small-cap company.
Does HYFT pay dividends?
No, MindWalk Holdings Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALXO
ALX Oncology Holdings Inc.
$1.45
Mkt Cap: $0.1B
ATYR
aTyr Pharma, Inc.
$0.75
Mkt Cap: $0.1B
BYSI
BeyondSpring Inc.
$2.35
Mkt Cap: $0.1B
CAMP
CAMP4 Therapeutics Corporation
$6.38
Mkt Cap: $0.1B
CLNN
Clene Inc.
$6.68
Mkt Cap: $0.1B
FBIO
Fortress Biotech, Inc.
$3.54
Mkt Cap: $0.1B
GUTS
Fractyl Health, Inc. Common Stock
$2.20
Mkt Cap: $0.2B
QNCX
Quince Therapeutics, Inc.
$3.57
Mkt Cap: $0.2B
RPTX
Repare Therapeutics Inc.
$2.14
Mkt Cap: $0.1B
UNCY
Unicycive Therapeutics, Inc.
$5.56
Mkt Cap: $0.1B
Explore stocks similar to HYFT for comparison